Cart
0
Product
Products
(empty)
No products
To be determined
Shipping
$0.00
Total
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart.
There is 1 item in your cart.
Total products
Total shipping
To be determined
Total
Data sheet
| Assay time | 90 minutes |
| Validity | 6 months |
| Specificity | SARS-CoV-2 RBD IgM |
| Assay Range | qualitative, positive control, negative control |
| Size | 96T |
| Storage | 2 - 8 ℃ |
| Application | Detect neutralization IgM against S1-RBD |
| Background | SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus 2) has caused a disruptive worldwide viral pandemic. The quest for effective vaccine countermeasures is an active pursuit in the biomedical research community. The spike (S) protein on the virus surface is instrumental for binding, fusing, and entry into host cells, and is also the lead immunogen for several advanced vaccine candidates. The S protein contains the receptor‐binding domain (RBD) that binds to the host receptor, angiotensin‐converting enzyme 2 (ACE2). The RBD is an appealing antigen for vaccine development, as most neutralizing antibodies generated during a SARS‐CoV‐2 infection are directed against it. |
| Sample type | Serum, 10 µL |